Chromatin immunoprecipitation (ChIP) for histone modifications and RNA polymerase II

KQ Kylie M. Quinn
WK Wan-Ting Kan
KW Katherine A. Watson
BL Brian J. Liddicoat
NS Natasha G. Swan
HM Hayley McQuilten
AD Alice E. Denton
JL Jasmine Li
WC Weisan Chen
LB Lorena E. Brown
DJ David C. Jackson
PR Patrick C. Reading
PD Peter C. Doherty
KK Katherine Kedzierska
LK Lukasz Kedzierski
ST Stephen J. Turner
NG Nicole L. La Gruta
request Request a Protocol
ask Ask a question
Favorite

Sort purified lymphocytes from LNs and spleen (~5 x 106 cells total) were fixed in 1% formaldehyde, resuspended in ChIP lysis buffer (1% v/v SDS, 10mM EDTA, 50 mM Tris-HCl) and sonicated to generate 200–1000 base pair fragments. Samples were then precleared using Protein A-agarose/salmon sperm DNA (Millipore, 16–157), split into 5 and incubated overnight with either 5 ug anti-H3K27me3, 3 ug anti-H3K4me3 or 4 ug anti-RNA polymerase II (all Invitrogen). A no antibody control and a total input positive control were also included. After washing, all samples (except the ‘total input’) were incubated with Protein A-agarose/salmon sperm DNA with rotation for 1 hour followed by a series of washes in low salt, high salt, lithium chloride, and TE buffers. DNA was eluted before crosslink reversal with 0.2M NaCl at 66°C overnight, followed by protein digestion with proteinase K (Promega). Immunoprecipitated DNA was extracted by phenol: chloroform:isoamyl (25:24:1) extraction and resuspended in HPLC water. For analysis, real-time PCR was used to measure the levels of ChIP-DNA, such that resulting cycle threshold (Ct) values were converted to copy number (#copies = 105/2Ct-17) and samples were normalised to their corresponding total inputs with background subtraction (no-antibody control).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A